Nov 09, 2023 / 05:35PM GMT
Robyn Kay Shelton Karnauskas - Truist Securities, Inc., Research Division - Research Analyst
All right. Good afternoon. Thanks so much for joining us. I'm Robyn Karnauskas, one of the biotech analysts at Truist. I'm so excited to have for a keynote this afternoon from Pfizer, Aamir Malik, the Chief Business Innovation Officer and Executive Vice President. So thank you very much for taking the time and doing this talk instead of doing more important things. I really appreciate it.
Aamir Malik - Pfizer Inc. - Executive VP & Chief Business Innovation Officer
It's nice to be with you. Thanks for having me.
Questions and Answers:
Robyn Kay Shelton Karnauskas - Truist Securities, Inc., Research Division - Research AnalystSo I guess the first question is, given your role as the Chief Business Innovation Officer, how do you see Pfizer's approach to innovation compared to other pharma companies? And how does Pfizer think about this differently?
Aamir Malik - Pfizer Inc. - Executive VP